Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications
Authors:
Open Access
- 16 May 2023
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 42 (24) , 1970-1979
Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. Understanding the cancer mechanisms provides novel diagnostic, prognostic, and therapeutic markers for the management of HCC disease. In addition to genomic and epigenomic regulation, post-translational modification exerts a profound influence on protein functions and plays a critical role in regulating various biological processes. Protein glycosylation is one of the most common and complex post-translational modifications of newly synthesized proteins and acts as an important regulatory mechanism that is implicated in fundamental molecular and cell biology processes. Recent studies in glycobiology suggest that aberrant protein glycosylation in hepatocytes contributes to the malignant transformation to HCC by modulating a wide range of pro-tumorigenic signaling pathways. The dysregulated protein glycosylation regulates cancer growth, metastasis, stemness, immune evasion, and therapy resistance, and is regarded as a hallmark of HCC. Changes in protein glycosylation could serve as potential diagnostic, prognostic, and therapeutic factors in HCC. In this review, we summarize the functional importance, molecular mechanism, and clinical application of protein glycosylation alterations in HCC.Keywords
This publication has 97 references indexed in Scilit:
- Caveolin‐1 up‐regulates integrin α2,6‐sialylation to promote integrin α5β1‐dependent hepatocarcinoma cell adhesionFEBS Letters, 2013
- Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma TissueCancer Epidemiology, Biomarkers & Prevention, 2012
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene familyGlycobiology, 2011
- The intersections betweenO-GlcNAcylation and phosphorylation: implications for multiple signaling pathwaysJournal of Cell Science, 2010
- Identification and Confirmation of Biomarkers Using an Integrated Platform for Quantitative Analysis of Glycoproteins and Their GlycosylationsJournal of Proteome Research, 2009
- Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2009
- Alteration of protein glycosylation in liver diseasesJournal of Hepatology, 2009
- Detection of Hepatocellular Carcinoma Using Glycomic AnalysisClinical Cancer Research, 2009
- N-glycan alterations are associated with drug resistance in human hepatocellular carcinomaMolecular Cancer, 2007
- Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α-fetoproteinHepatology, 1998